Table 14.
CG Type | Virus Type | Experimental System | Anti-Viral Asssay | IC50 (µg/mL) | Ref |
---|---|---|---|---|---|
κ/ι/ν-CG | DENV2 | Vero cells, human hepatoma HepG2, and foreskin PH cells | Plaque formation | 1 | [39] |
ι/λ/κ-CG | DENV1, 2, 3, 4 | Vero cells, human hepatoma HepG2, and foreskin PH cells | Plaque formation | 0.1–40.7 | [36] |
ι/λ/κ-CG | DENV2 | Vero cells and C6/36 HT mosquito cells | Plaque formation | 0.4/7 | [38] |
ι-CG | DENV2 | Vero cells and C6/36 HT mosquito cells | Plaque formation | 22.5/0.64 | [16] |
CG | DENV2 | BHK-21 fibroblast cells | Measuring cellular oxygen consumption rate | 10 | [29] |
λ-CG | DENV2 | Vero cells and C6/36 HT mosquito cells | Plaque formation | >50 | [37] |